The Cigna Group$271.10UNH · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B |
| Cost of Revenue | $50.66B | $46.69B | $38.77B | $33.70B | $31.03B | $30.75B | $28.12B | $27.00B |
| Selling, General & Administrative | $59.59B | $53.01B | $54.63B | $47.78B | $42.58B | $41.70B | $35.19B | $34.07B |
| Operating Expenses | $428.60B | $367.99B | $339.26B | $295.73B | $263.63B | $234.74B | $222.47B | $208.90B |
| Operating Income | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B |
| Interest Expense | $4.00B | $3.91B | $3.25B | $2.09B | $1.66B | $1.66B | $1.70B | $1.40B |
| Income Before Taxes | $14.70B | $20.07B | $29.11B | $26.34B | $22.31B | $20.74B | $17.98B | $15.94B |
| Provision for Income Taxes | $1.89B | $4.83B | $5.97B | $5.70B | $4.58B | $4.97B | $3.74B | $3.56B |
| Net Income | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B |
| Basic EPS | $13.28 | $15.64 | $24.12 | $21.47 | $18.33 | $16.23 | $14.55 | $12.45 |
| Diluted EPS | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 | $16.03 | $14.33 | $12.19 |
| Basic Shares Outstanding | 908.00M | 921.00M | 928.00M | 937.00M | 943.00M | 949.00M | 951.00M | 963.00M |
| Diluted Shares Outstanding | 911.00M | 929.00M | 938.00M | 950.00M | 956.00M | 961.00M | 966.00M | 983.00M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $19.69 | $18.28 | $20.00 | 13 | ↑12 ↓0 |
| Dec 2027 | $22.42 | $21.20 | $24.00 | 13 | ↑11 ↓0 |
| Dec 2028 | $26.14 | $24.93 | $28.15 | 7 | ↑6 ↓0 |
| Dec 2029 | $30.02 | $30.02 | $30.02 | 1 | ↑0 ↓0 |
